|
US2833010A
(en)
|
1954-02-01 |
1958-05-06 |
Rosenthal Harry |
Laundry clip
|
|
CA1163561A
(en)
|
1979-11-06 |
1984-03-13 |
Cyril Boroda |
Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
|
|
US4450175A
(en)
|
1982-09-23 |
1984-05-22 |
Warshaw Thelma G |
Method and compositions for treating acne
|
|
US20030206899A1
(en)
|
1991-03-29 |
2003-11-06 |
Genentech, Inc. |
Vascular endothelial cell growth factor antagonists
|
|
US6582959B2
(en)
|
1991-03-29 |
2003-06-24 |
Genentech, Inc. |
Antibodies to vascular endothelial cell growth factor
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
AU687727B2
(en)
|
1992-10-28 |
1998-03-05 |
Genentech Inc. |
Vascular endothelial cell growth factor antagonists
|
|
US5698589A
(en)
|
1993-06-01 |
1997-12-16 |
International Medical Innovations, Inc. |
Water-based topical cream containing nitroglycerin and method of preparation and use thereof
|
|
US5504117A
(en)
|
1994-05-27 |
1996-04-02 |
Neptune Pharmaceutical Corporation |
Pharmacologic preparation for the treatment of anal disorders
|
|
JP3211892B2
(ja)
|
1994-05-27 |
2001-09-25 |
セイジィ ファーマスーティカルス インコーポレーテッド |
肛門疾患を治療する窒素酸化物供与体及び方法
|
|
IL117645A
(en)
|
1995-03-30 |
2005-08-31 |
Genentech Inc |
Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
|
|
PT971959E
(pt)
|
1997-04-07 |
2006-05-31 |
Genentech Inc |
Anticorpos humanizados e metodos para formar anticorpos humanizados
|
|
US20020032315A1
(en)
|
1997-08-06 |
2002-03-14 |
Manuel Baca |
Anti-vegf antibodies
|
|
KR100816621B1
(ko)
|
1997-04-07 |
2008-03-24 |
제넨테크, 인크. |
항-ｖｅｇｆ 항체
|
|
GB9802078D0
(en)
|
1998-01-30 |
1998-03-25 |
Futura Medical Limited |
Preparation for treatment of erectile dysfunction
|
|
US6103275A
(en)
|
1998-06-10 |
2000-08-15 |
Nitric Oxide Solutions |
Systems and methods for topical treatment with nitric oxide
|
|
GB9818524D0
(en)
|
1998-08-25 |
1998-10-21 |
Futura Medical Limited |
Inorgasmia treatment
|
|
US6492398B1
(en)
|
1999-03-04 |
2002-12-10 |
Smithkline Beechman Corporation |
Thiazoloindolinone compounds
|
|
GB9904930D0
(en)
|
1999-03-04 |
1999-04-28 |
Glaxo Group Ltd |
Thiazoloindolinone compounds
|
|
US6703020B1
(en)
|
1999-04-28 |
2004-03-09 |
Board Of Regents, The University Of Texas System |
Antibody conjugate methods for selectively inhibiting VEGF
|
|
US20040191276A1
(en)
|
1999-11-30 |
2004-09-30 |
Cutispharma, Inc. |
Compositions and kits for compounding pharmaceuticals
|
|
US20020049188A1
(en)
|
1999-12-15 |
2002-04-25 |
Azarnoff Daniel L. |
Nitroglycerin ointment for treatment of pain associated with anal disease
|
|
US6620818B1
(en)
|
2000-03-01 |
2003-09-16 |
Smithkline Beecham Corporation |
Method for reducing the severity of side effects of chemotherapy and/or radiation therapy
|
|
WO2001070255A2
(en)
|
2000-03-20 |
2001-09-27 |
Pfizer Products, Inc. |
Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor
|
|
ES2232613T3
(es)
*
|
2000-04-26 |
2005-06-01 |
Cellegy Pharmaceuticals, Inc |
Formulaciones y metodos de utilizacion de agentes mimeticos del oxido nitrico contra un fenotipo celular maligno.
|
|
US20030157037A1
(en)
|
2000-05-24 |
2003-08-21 |
Joachim Bunger |
Use of aryl oximes for the prophylaxis and/or treatment of erythema formation and/or inflammatory reaction of the skin
|
|
KR20030065463A
(ko)
|
2000-08-11 |
2003-08-06 |
데이비드 알. 휘트록 |
질소 산화물 및 질소 산화물 전구체의 생산을 증가시키기위한 암모니아 산화 박테리아를 포함하는 조성물 및 이를이용하는 방법
|
|
US6780849B2
(en)
|
2000-12-21 |
2004-08-24 |
Scimed Life Systems, Inc. |
Lipid-based nitric oxide donors
|
|
WO2002069906A2
(en)
|
2001-03-06 |
2002-09-12 |
Cellegy Pharmaceuticals, Inc. |
Compounds and methods for the treatment of urogenital disorders
|
|
CN1308438C
(zh)
|
2002-01-11 |
2007-04-04 |
大卫·R·怀特洛克 |
含有氨氧化细菌的化合物以及使用的方法
|
|
US6979688B2
(en)
|
2002-02-12 |
2005-12-27 |
Ford John P |
Treatment method against side-effects of chemotherapy
|
|
US7816366B2
(en)
|
2002-02-12 |
2010-10-19 |
Asymmetric Therapeutics, Llc |
Compositions and methods for treating and preventing dermatoses
|
|
US6995165B2
(en)
|
2002-02-12 |
2006-02-07 |
Ford John P |
Methods, compositions, and kits for organ protection during systemic anticancer therapy
|
|
AU2003223491A1
(en)
|
2002-04-05 |
2003-10-27 |
Nitromed, Inc. |
Nitric oxide donors, compositions and methods of use
|
|
WO2004009253A1
(en)
|
2002-07-19 |
2004-01-29 |
University Of North Carolina At Chapel Hill |
Surface-localized release of an anti-biofouling agent via micropatterning
|
|
UA101945C2
(uk)
|
2003-05-30 |
2013-05-27 |
Дженентек, Инк. |
Лікування злоякісного новоутворення за допомогою бевацизумабу
|
|
NZ545001A
(en)
|
2003-07-03 |
2009-09-25 |
Univ St Andrews |
Zeolites for delivery of nitric oxide
|
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
|
WO2005044853A2
(en)
|
2003-11-01 |
2005-05-19 |
Genentech, Inc. |
Anti-vegf antibodies
|
|
CN1997731A
(zh)
|
2003-09-26 |
2007-07-11 |
大卫·R·怀特洛克 |
使用氨氧化细菌的方法
|
|
EP1667646A4
(en)
|
2003-09-26 |
2007-07-04 |
David R Whitlock |
METHOD FOR USE OF AMMONIA-OXIDATING BACTERIA
|
|
EP1732577B1
(en)
|
2004-02-23 |
2013-04-10 |
Strategic Science & Technologies, LLC |
Topical delivery of l-arginine to improve body and skin appearance
|
|
CN1568943A
(zh)
|
2004-04-26 |
2005-01-26 |
江苏省药物研究所 |
硝酸甘油软膏及其制备方法和应用
|
|
US20060009360A1
(en)
|
2004-06-25 |
2006-01-12 |
Robert Pifer |
New adjuvant composition
|
|
EP1871433B1
(en)
|
2005-03-24 |
2009-04-22 |
NOLabs AB |
Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor
|
|
EP1704876A1
(en)
|
2005-03-24 |
2006-09-27 |
NOLabs AB |
Cosmetic treatment, device for performing said treatment and manufacturing method thereof
|
|
CA2603785C
(en)
|
2005-04-15 |
2014-07-22 |
Roman Perez-Soler |
Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy
|
|
DK2439273T3
(da)
|
2005-05-09 |
2019-06-03 |
Ono Pharmaceutical Co |
Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika
|
|
WO2006127591A2
(en)
|
2005-05-23 |
2006-11-30 |
Nitromed, Inc. |
Organic nitric oxide enhancing salts of nonsteroidal antiinflammatory compounds, compositions and methods of use
|
|
EP1888510A4
(en)
|
2005-05-27 |
2013-01-16 |
Univ North Carolina |
NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS
|
|
PT1907424E
(pt)
|
2005-07-01 |
2015-10-09 |
Squibb & Sons Llc |
Anticorpos monoclonais humanos para o ligando 1 de morte programada (pd-l1)
|
|
CN101283275A
(zh)
|
2005-10-11 |
2008-10-08 |
默克专利有限公司 |
趋化因子表达的依赖egfr的调控和对肿瘤的诊断和治疗的影响及其副作用
|
|
US20070172847A1
(en)
|
2005-11-15 |
2007-07-26 |
The Regents Of The University Of California |
Molecular signaling pathways triggered by rituximab: prognostic, diagnostic, and therapeutic uses
|
|
WO2007138103A1
(en)
|
2006-06-01 |
2007-12-06 |
Nobera Pharma, S.L. |
Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
|
|
EP2043685B1
(en)
|
2006-07-03 |
2015-12-23 |
Genmab A/S |
Prevention of rash in patients undergoing anti-egfr therapy
|
|
GB0616350D0
(en)
|
2006-08-17 |
2006-09-27 |
Univ St Andrews |
Adsorption and release of nitric oxide in metal organic frameworks
|
|
US8399005B2
(en)
|
2007-10-12 |
2013-03-19 |
University Of North Carolina At Chapel Hill |
Use of nitric oxide to enhance the efficacy of silver and other topical wound care agents
|
|
WO2009100367A2
(en)
|
2008-02-06 |
2009-08-13 |
Adherex Technologies Inc. |
Compositions comprising topical dpd inhibitors and methods of using same in the treatment of hand-foot syndrome
|
|
CN101970499B
(zh)
|
2008-02-11 |
2014-12-31 |
治疗科技公司 |
用于肿瘤治疗的单克隆抗体
|
|
EP2262837A4
(en)
|
2008-03-12 |
2011-04-06 |
Merck Sharp & Dohme |
PD-1 BINDING PROTEINS
|
|
US8815953B2
(en)
|
2008-03-13 |
2014-08-26 |
Spectrum Pharmaceuticals, Inc. |
Formulations of vitamin K analogs for topical use
|
|
FR2929278A1
(fr)
|
2008-04-01 |
2009-10-02 |
Centre Nat Rech Scient |
Solide hybride cristallin poreux pour l'adsorption et la liberation de gaz a interet biologique.
|
|
US20100016446A1
(en)
|
2008-07-21 |
2010-01-21 |
Sylvia Gonda |
Stable water-based topical pharmaceutical creams and methods of making and using same
|
|
AU2009288730B2
(en)
|
2008-08-25 |
2013-06-20 |
Amplimmune, Inc. |
Compositions of PD-1 antagonists and methods of use
|
|
WO2010037095A2
(en)
*
|
2008-09-29 |
2010-04-01 |
Nometics |
Agents and methods for the treatment of cancer
|
|
WO2010044875A2
(en)
|
2008-10-16 |
2010-04-22 |
Novan, Inc. |
Nitric oxide releasing particles for oral care applications
|
|
EP3255060A1
(en)
|
2008-12-09 |
2017-12-13 |
F. Hoffmann-La Roche AG |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
EP2201942A1
(de)
|
2008-12-23 |
2010-06-30 |
Intendis GmbH |
Zusammensetzung mit Hanföl für die Behandlung topischer Erkrankungen
|
|
EP2246057A1
(en)
|
2009-04-29 |
2010-11-03 |
Nobera Pharma, S.L. |
Use of allopurinol for the treatment of hand foot skin reaction
|
|
WO2010148572A1
(en)
*
|
2009-06-26 |
2010-12-29 |
Asan Laboratories Co., Ltd. |
Method for treating or ameliorating mucocutaneous or ocular toxicities
|
|
JP6159084B2
(ja)
|
2009-06-30 |
2017-07-05 |
デルマン バイオメディシン カンパニー リミテッド |
酒さまたは赤面に関連する皮膚疾患を治療するための、ベルベリンまたはその類似体を含有する組成物
|
|
BR112012003804B1
(pt)
|
2009-08-21 |
2019-02-19 |
Novan, Inc. |
Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
|
|
WO2011022652A1
(en)
|
2009-08-21 |
2011-02-24 |
Novan, Inc. |
Topical gels
|
|
WO2011047013A1
(en)
|
2009-10-13 |
2011-04-21 |
Novan, Inc. |
Nitric oxide-releasing coatings
|
|
JP2013508295A
(ja)
|
2009-10-16 |
2013-03-07 |
デューク・ユニヴァーシティ |
薬物誘発性手足症候群を治療するための組成物および方法
|
|
US20110190244A1
(en)
|
2010-02-01 |
2011-08-04 |
Peter Maccallum Cancer Institute |
Method of treatment of egfr inhibitor toxicity
|
|
WO2011097360A1
(en)
|
2010-02-05 |
2011-08-11 |
Deland M Maitland |
Led treatment of dermatologic toxicities associated with epidermal growth factor receptor inhibitors
|
|
US8795263B2
(en)
|
2010-02-05 |
2014-08-05 |
M. Maitland DeLand |
LED treatment of dermatologic toxicities associated with multikinase inhibitors
|
|
WO2011097358A1
(en)
|
2010-02-05 |
2011-08-11 |
Deland M Maitland |
Led treatment of dermatologic toxicities associated with vascular endothelial growth factor inhibitors
|
|
EP2368549A1
(en)
|
2010-03-25 |
2011-09-28 |
BioAlliance Pharma |
Treating hand-foot syndrome and related pathologies using clonidine or its derivatives
|
|
US8729056B2
(en)
|
2010-03-31 |
2014-05-20 |
Ono Pharmaceutical Co., Ltd. |
Preventive and/or therapeutic agent of hand-foot syndrome
|
|
WO2012055057A1
(en)
|
2010-10-29 |
2012-05-03 |
Neurotune Ag |
Therapeutic use of dimiracetam to prevent the hand & foot syndrome caused by sorafenib
|
|
US8591876B2
(en)
|
2010-12-15 |
2013-11-26 |
Novan, Inc. |
Methods of decreasing sebum production in the skin
|
|
EP2665763B1
(en)
|
2011-01-20 |
2015-08-26 |
Novan, Inc. |
Temperature controlled sol-gel co-condensation
|
|
ES2695173T3
(es)
|
2011-02-28 |
2019-01-02 |
Novan Inc |
Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
|
|
CN111789956B
(zh)
|
2011-04-27 |
2023-02-17 |
耶鲁大学 |
用于抑制化疗引起副作用的药物治疗、筛选技术和试剂盒
|
|
WO2012153331A2
(en)
|
2011-05-09 |
2012-11-15 |
Topical Therapeutic Agent (Tta) Ltd. |
Nitric oxide-sequestering topical formulations
|
|
EP2729174A1
(en)
|
2011-07-08 |
2014-05-14 |
Merck Sharp & Dohme Corp. |
Il-23 antagonists for treatment or prevention of skin rash associated with treatment with p13k/akt pathway inhibitors
|
|
ES2658897T3
(es)
|
2011-08-24 |
2018-03-12 |
Novan, Inc. |
Macromoléculas de liberación de óxido nítrico ajustables que tienen múltiples estructuras donantes de óxido nítrico
|
|
WO2013063354A1
(en)
|
2011-10-27 |
2013-05-02 |
Novan, Inc. |
Nitric oxide releasing bath compositions and methods of using the same
|
|
CN103127504A
(zh)
|
2011-12-05 |
2013-06-05 |
尼奥克斯(文莱)控股有限公司 |
局部产生一氧化氮的组合物和方法
|
|
EP2601965A1
(en)
|
2011-12-06 |
2013-06-12 |
Apeiron Biologics AG |
Compositions for preventing or treating adverse reactions of EGFR inhibition
|
|
EP2798365A1
(en)
|
2011-12-27 |
2014-11-05 |
Université Catholique de Louvain |
Method for measuring nitric oxide in blood
|
|
US20150111973A1
(en)
|
2012-03-13 |
2015-04-23 |
Novan, Inc. |
Methods of modulating steroid hormone activity
|
|
ES2861439T3
(es)
|
2012-03-14 |
2021-10-06 |
Novan Inc |
Composiciones farmacéuticas que liberan óxido nítrico
|
|
WO2013157891A1
(ko)
|
2012-04-19 |
2013-10-24 |
부산대학교 산학협력단 |
Ｅｇｆｒ 억제제 유발 피부 부작용의 예방 또는 치료용 국소용 약학 조성물
|
|
CN103446261B
(zh)
|
2012-06-05 |
2015-04-15 |
中国医学科学院肿瘤医院 |
一种预防和/或治疗肿瘤治疗相关皮肤损害的中药组合物
|
|
EP2885323B1
(en)
|
2012-08-17 |
2023-08-30 |
The University of North Carolina At Chapel Hill |
Water soluble nitric oxide-releasing polyglucosamines and uses thereof
|
|
EP2700413B1
(en)
|
2012-08-20 |
2015-10-14 |
Bionoox Suisse SA |
Composition comprising dihydroquercetin, alpha-tocopherol and bisabolol
|
|
US9187501B2
(en)
|
2012-08-28 |
2015-11-17 |
The University Of North Carolina At Chapel Hill |
Nitric oxide-releasing nanorods and their methods of use
|
|
US8871256B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and systems for treatment of inflammatory diseases with nitric oxide
|
|
US8871254B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
|
|
US9855211B2
(en)
|
2013-02-28 |
2018-01-02 |
Novan, Inc. |
Topical compositions and methods of using the same
|
|
EP2978412A2
(en)
*
|
2013-03-25 |
2016-02-03 |
Sloan Kettering Institute For Cancer Research |
Articles and methods for preventing and treating dermatologic adverse events
|
|
GB201305947D0
(en)
|
2013-04-02 |
2013-05-15 |
Univ Sheffield |
New method 1
|
|
US20150313896A1
(en)
|
2013-07-26 |
2015-11-05 |
Galderma Research & Development |
Method for treating cell proliferation disorders
|
|
US11813284B2
(en)
|
2013-08-08 |
2023-11-14 |
Novan, Inc. |
Topical compositions and methods of using the same
|
|
TW201538156A
(zh)
|
2013-12-19 |
2015-10-16 |
Twi Biotechnology Inc |
小蘗鹼配方及其用途
|
|
US20160263092A1
(en)
|
2013-12-19 |
2016-09-15 |
Twi Biotechnology, Inc. |
Therapeutic uses of berberine formulations
|
|
KR20210100224A
(ko)
|
2014-04-15 |
2021-08-13 |
에이오바이오미 엘엘씨 |
암모니아-산화 니트로소모나스 유트로파 균주 d23
|
|
US10078054B2
(en)
|
2014-05-08 |
2018-09-18 |
Aobiome Llc |
Systems and methods for detecting nitric oxide
|
|
CA2949833C
(en)
|
2014-05-22 |
2024-06-11 |
Aobiome Llc |
Methods of preparing materials with ammonia oxidizing bacteria and testing materials for ammonia oxidizing bacteria
|
|
US10383900B2
(en)
|
2014-05-22 |
2019-08-20 |
Aobiome Llc |
Systems and methods for storage and delivery of ammonia oxidizing bacteria
|
|
US20170202917A1
(en)
|
2014-05-29 |
2017-07-20 |
Daewoong Pharmaceutical Co., Ltd. |
Pharmaceutical composition for preventing or treating skin rash
|
|
BR112016030275A2
(pt)
|
2014-06-24 |
2017-08-22 |
Galderma Sa |
Métodos para tratamento e redução dos sintomas da síndrome mão-pé (eritrodisestesia palmo-plantar)
|
|
WO2016160089A1
(en)
|
2015-03-27 |
2016-10-06 |
Novan, Inc. |
Topical antiviral compositions, delivery systems, and methods of using the same
|
|
EP3166593B1
(en)
|
2014-07-11 |
2020-05-20 |
Novan, Inc. |
Topical antiviral compositions and methods of using the same
|
|
US10925689B2
(en)
|
2014-07-14 |
2021-02-23 |
Novan, Inc. |
Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
|
|
EP3177262A4
(en)
|
2014-08-08 |
2018-04-18 |
Novan Inc. |
Topical emulsions
|
|
KR20170060042A
(ko)
*
|
2014-09-13 |
2017-05-31 |
노파르티스 아게 |
Alk 억제제의 조합 요법
|
|
EP3034092A1
(en)
*
|
2014-12-17 |
2016-06-22 |
Université de Lausanne |
Adoptive immunotherapy for treating cancer
|
|
CN204411249U
(zh)
|
2014-12-26 |
2015-06-24 |
朴瑛 |
一种肿瘤患者化疗后手足综合症的多功能康复装置
|
|
WO2016161285A1
(en)
|
2015-04-02 |
2016-10-06 |
Aobiome Llc |
Production of nitro-fatty acids and nitro-hydrocarbons by ammonia oxidizing bacteria
|
|
EP3313520A4
(en)
|
2015-06-24 |
2019-01-02 |
TWI Biotechnology, Inc. |
Therapeutic uses of berberine formulations
|
|
WO2017004557A1
(en)
|
2015-07-02 |
2017-01-05 |
Aobiome Llc |
Ammonia oxidizing bacteria for treatment of acne
|
|
CN109069878A
(zh)
|
2015-07-02 |
2018-12-21 |
Ao生物医学有限责任公司 |
微生物群系相容性化妆品
|
|
WO2017009824A1
(en)
|
2015-07-16 |
2017-01-19 |
Neotech-Kordan Group Ltd. |
Formulation methods and ointment formulations therein containing uracil, thymine, and/or their derivatives for treatment and prevention of hand-and-foot syndrome
|
|
WO2017019614A1
(en)
|
2015-07-28 |
2017-02-02 |
Novan, Inc. |
Combinations and methods for the treatment and/or prevention of fungal infections
|
|
WO2017029647A1
(en)
|
2015-08-20 |
2017-02-23 |
Meir Eini |
Tetracycline management of egfr inhibitor associated dermatoses
|
|
US11420986B2
(en)
|
2015-11-02 |
2022-08-23 |
The University Of North Carolina At Chapel Hill |
Functionalized mesoporous silica via an aminosilane surfactant ion exchange reaction: controlled scaffold design and nitric oxide release
|
|
CN105381070A
(zh)
|
2015-12-22 |
2016-03-09 |
浙江大学 |
犀角地黄药物组合物在制备预防及治疗表皮生长因子受体抑制剂所致相关皮疹药物中的用途
|
|
US10912743B2
(en)
|
2016-03-02 |
2021-02-09 |
Novan, Inc. |
Compositions for treating inflammation and methods of treating the same
|
|
JP2019507794A
(ja)
|
2016-03-10 |
2019-03-22 |
ルトリス ファーマ エル ティー ディー． |
皮膚反応を治療するためのｂｒａｆ阻害剤の使用
|
|
EP3432926A4
(en)
|
2016-03-21 |
2019-11-20 |
Mayo Foundation for Medical Education and Research |
METHOD FOR REDUCING THE TOXICITY OF CHEMOTHERAPEUTICS
|
|
WO2017223182A1
(en)
|
2016-06-22 |
2017-12-28 |
Medchem Partners, Llc. |
Nitric oxide donors
|
|
CN109689076A
(zh)
|
2016-07-19 |
2019-04-26 |
Ao生物医学有限责任公司 |
用于胃肠系统使用和递送至胃肠系统的氨氧化微生物
|
|
BR112019005536A2
(pt)
|
2016-09-21 |
2019-06-25 |
Aobiome Llc |
microrganismos oxidantes de amônia para uso e entrega para o sistema intranasal
|
|
AU2017375944A1
(en)
|
2016-12-12 |
2019-07-04 |
Aobiome Llc |
Ammonia oxidizing microorganisms for the regulation of blood pressure
|
|
CN106539924A
(zh)
|
2016-12-22 |
2017-03-29 |
张丽燕 |
一种预防和缓解化疗所致手足综合症的中药手套和袜子
|
|
CN107158287A
(zh)
|
2017-03-25 |
2017-09-15 |
许进秀 |
缓解吉非替尼/厄洛替尼引起的皮肤毒性的中药
|
|
CN107412455A
(zh)
|
2017-04-21 |
2017-12-01 |
曹师磊 |
一种治疗皮疹的天然外用药物组合物及其制备方法
|
|
CN107198718A
(zh)
|
2017-05-04 |
2017-09-26 |
常州桐树生物科技有限公司 |
一种外用治疗皮疹的中药组合物及其制备方法和应用
|
|
JP7103363B2
(ja)
|
2017-09-21 |
2022-07-20 |
味の素株式会社 |
手足症候群の予防または改善用組成物
|
|
JP2021506958A
(ja)
*
|
2017-12-13 |
2021-02-22 |
オンクォリティ ファーマシューティカルズ チャイナ エルティーディーＯｎｑｕａｌｉｔｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｈｉｎａ Ｌｔｄ． |
Ｅｇｆｒ阻害に関連する疾患を予防又は治療する方法
|